SCHEMBL380987

SCHEMBL380987

CC(C)(C)N(C(=O)O)C(CNS(C)(=O)=O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.40
BCHE P06276 2/20 0.39
TRPV4 Q9HBA0 1/20 0.38
NPSR1 Q6W5P4 2/20 0.38
CES2 O00748 1/20 0.38
ACP3 P15309 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MMP7 P09237 1/20 0.38
NR3C1 P04150 1/20 0.38
OPRK1 P41145 1/20 0.38
PNMT P11086 1/20 0.38
GPR139 Q6DWJ6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL381880 0.90 SMN1; SMN2 (0.42) ALDH1A1CYP3A4CYP2C9SMN1; SMN2MEN1
SCHEMBL19244815 0.85 ACP3 (0.40) ALDH1A1CYP3A4CYP2C9SMN1; SMN2MEN1
SCHEMBL381695 0.84 OPRM1 (0.43) ALDH1A1CYP3A4CYP2C9SMN1; SMN2MEN1
SCHEMBL381593 0.83 BCHE (0.41) ALDH1A1CYP3A4CYP2C9SMN1; SMN2MEN1
SCHEMBL381185 0.82 ACP3 (0.47) ALDH1A1CYP3A4CYP2C9SMN1; SMN2MEN1
SCHEMBL15170368 0.82 ACP3 (0.47) ALDH1A1CYP3A4CYP2C9SMN1; SMN2MEN1
SCHEMBL19244872 0.81 OPRM1 (0.48) ALDH1A1CYP3A4CYP2C9SMN1; SMN2MEN1
SCHEMBL16674214 0.81 PNMT (0.52) ALDH1A1CYP3A4CYP2C9SMN1; SMN2MEN1
SCHEMBL414657 0.81 ACP3 (0.43) ALDH1A1CYP3A4CYP2C9SMN1; SMN2MEN1
SCHEMBL19244821 0.81 ACP3 (0.39) ALDH1A1CYP3A4CYP2C9SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408751-B1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof BAYER IP GMBH (DE) 2017-08-23 EP disclosed
EP-2408751-A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof Bayer Pharma Aktiengesellschaft (DE) 2012-01-25 EP disclosed
WO-2010105770-A1 SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-09-23 WO disclosed